Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11015198 Products and compositions

Patent 11015198 was granted and assigned to Silence Therapeutics PLC on May, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Judith Hauptmann0

Christian Frauendorf0

Dmitry Samarsky0

Date of Patent

May 25, 2021

0

Patent Application Number

164970000

Date Filed

April 5, 2018

0

Patent Citations

US Patent 10612027 Modified double-stranded RNA agents

0

US Patent 10233448 Modified double-stranded RNA agents

0

US Patent 10612024 Modified double-stranded RNA agents

US Patent 10633654 Modified RNAi polynucleotides and uses thereof

Patent Citations Received

US Patent 12084656 Products and compositions

0

US Patent 11414660 Products and compositions

US Patent 11879125 GalNAc compositions for improving siRNA bioavailability

0

US Patent 11987794 Products and compositions

0

US Patent 12076335 Nucleic acids for inhibiting expression of TMPRSS6 and iron chelators

0

Patent Primary Examiner

0

Patent abstract

The present invention relates to products and compositions and their uses. In particular the invention relates to nucleic acid products that interfere with gene expression or inhibits its expression and therapeutic uses such as for the treatment of disease and disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11015198 Products and compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool